Evidence map›Paper›PMID 34808603›Full record

ArticlePhysics in medicine and biology2021

Prostate and dominant intraprostatic lesion segmentation on PET/CT using cascaded regional-net.

Luke A Matkovic, Tonghe Wang, Yang Lei, Oladunni O Akin-Akintayo, Olayinka A Abiodun Ojo, Akinyemi A Akintayo, Justin Roper, Jeffery D Bradley, Tian Liu, David M Schuster and 1 more

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. A review of artificial intelligence in brachytherapy.Journal of applied clinical medical physics · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Lesion segmentation onFrontiers in oncology · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Luke A MatkovicDepartment of Radiation Oncology, Emory University, Atlanta, GA, United States of America.
Tonghe WangDepartment of Radiation Oncology, Emory University, Atlanta, GA, United States of America.
Yang LeiDepartment of Radiation Oncology, Emory University, Atlanta, GA, United States of America.
Oladunni O Akin-AkintayoDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, United States of America.
Olayinka A Abiodun OjoDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, United States of America.
Akinyemi A AkintayoDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, United States of America.
Justin RoperDepartment of Radiation Oncology, Emory University, Atlanta, GA, United States of America.
Jeffery D BradleyDepartment of Radiation Oncology, Emory University, Atlanta, GA, United States of America.
Tian LiuDepartment of Radiation Oncology, Emory University, Atlanta, GA, United States of America.
David M SchusterWinship Cancer Institute, Emory University, Atlanta, GA, United States of America.
Xiaofeng YangDepartment of Radiation Oncology, Emory University, Atlanta, GA, United States of America.ORCID 0000-0001-9023-5855

Funding

Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas SouthwesternU01CA113913 · NCI · EMORY UNIVERSITY · PI Martin G. Sanda · 2005 to 2026
$16.4M
uPAR Targeted in Vivo Molecular Magnetic Resonance Imaging of....P50CA128301 · NCI · EMORY UNIVERSITY · PI SCHUSTER, DAVID MICHAEL · 2008 to 2012
$6.8M
Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor BoostR01CA215718 · NCI · EMORY UNIVERSITY · PI YANG, XIAOFENG · 2018 to 2022
$1.8M
NCI NIH HHS P50 CA128301NCI NIH HHS R01 CA215718NCI NIH HHS U01 CA113913
6 · The paper itself

Abstract

Focal boost to dominant intraprostatic lesions (DILs) has recently been proposed for prostate radiation therapy. Accurate and fast delineation of the prostate and DILs is thus required during treatment planning. In this paper, we develop a learning-based method using positron emission tomography (PET)/computed tomography (CT) images to automatically segment the prostate and its DILs. To enable end-to-end segmentation, a deep learning-based method, called cascaded regional-Net, is utilized. The first network, referred to as dual attention network, is used to segment the prostate via extracting comprehensive features from both PET and CT images. A second network, referred to as mask scoring regional convolutional neural network (MSR-CNN), is used to segment the DILs from the PET and CT within the prostate region. Scoring strategy is used to diminish the misclassification of the DILs. For DIL segmentation, the proposed cascaded regional-Net uses two steps to remove normal tissue regions, with the first step cropping images based on prostate segmentation and the second step using MSR-CNN to further locate the DILs. The binary masks of DILs and prostates of testing patients are generated on the PET/CT images by the trained model. For evaluation, we retrospectively investigated 49 prostate cancer patients with PET/CT images acquired. The prostate and DILs of each patient were contoured by radiation oncologists and set as the ground truths and targets. We used five-fold cross-validation and a hold-out test to train and evaluate our method. The mean surface distance and DSC values were 0.666 ± 0.696 mm and 0.932 ± 0.059 for the prostate and 0.814 ± 1.002 mm and 0.801 ± 0.178 for the DILs among all 49 patients. The proposed method has shown promise for facilitating prostate and DIL delineation for DIL focal boost prostate radiation therapy.

Indexed as

ProstateProstatic NeoplasmsHumansImage Processing, Computer-AssistedMalePelvisPositron Emission Tomography Computed TomographyRetrospective Studiesdeep learningdominant intraprostatic lesionPET/CTprostatesegmentation

Identifiers

PMID34808603
PMCPMC8725511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.